Correlation Between CTi Biopharma and Eiger Biopharmaceutica

Can any of the company-specific risk be diversified away by investing in both CTi Biopharma and Eiger Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTi Biopharma and Eiger Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CTi Biopharma Corp and Eiger Biopharmaceuticals, you can compare the effects of market volatilities on CTi Biopharma and Eiger Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTi Biopharma with a short position of Eiger Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTi Biopharma and Eiger Biopharmaceutica.

Diversification Opportunities for CTi Biopharma and Eiger Biopharmaceutica

-0.82

Correlation Coefficient

CTi Biopharma  Eiger Biopharmaceutica

Pay attention - limited upside

The 3 months correlation between CTi and Eiger is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding CTi Biopharma Corp and Eiger Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eiger Biopharmaceuticals and CTi Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTi Biopharma Corp are associated (or correlated) with Eiger Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eiger Biopharmaceuticals has no effect on the direction of CTi Biopharma i.e., CTi Biopharma and Eiger Biopharmaceutica go up and down completely randomly.

Pair Corralation between CTi Biopharma and Eiger Biopharmaceutica

If you would invest  74.00  in Eiger Biopharmaceuticals on September 3, 2024 and sell it today you would earn a total of  0.00  from holding Eiger Biopharmaceuticals or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

CTi Biopharma Corp  vs.  Eiger Biopharmaceuticals

CTi Biopharma Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CTi Biopharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, CTi Biopharma is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Eiger Biopharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eiger Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Eiger Biopharmaceutica is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with CTi Biopharma and Eiger Biopharmaceutica

The main advantage of trading using opposite CTi Biopharma and Eiger Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTi Biopharma position performs unexpectedly, Eiger Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eiger Biopharmaceutica will offset losses from the drop in Eiger Biopharmaceutica's long position.

The idea behind CTi Biopharma Corp and Eiger Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.